Company research / NHP

National Healthcare Properties, Inc. (NHP)

Also trades as HLTC, NHPBP. Every security a company lists rests on one set of financial statements, so these figures cover the whole company.

CIK 0001561032 · Nasdaq · Real Estate Investment Trusts

  • Sector Finance & Real Estate
  • Incorporated MD
  • Fiscal year ends Dec 31

For the year ended 2025-12-31, National Healthcare Properties, Inc. reported revenue of $342.28M. Revenue fell 3.3% from the prior annual period. Over the twelve months to 2026-06-30, revenue was $344.32M.

Key ratios (year ended 2025-12-31)

36.0%
Gross margin
1.0%
Operating margin
-16.9%
Net margin
-9.6%
Return on year-end equity
-3.3%
Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 4 (ownership change) · 2026-09-29

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

The first column covers the twelve months to 2026-06-30 from the latest quarterly report: flows are the last fiscal year plus this year to date minus the same months a year earlier, and balances are as of that date. Per-share figures are annual only.

Stock splits: 1-for-4, first reflected in a filing dated 2024-11-12. Figures are as filed: per-share figures and share counts last reported before a split are on the old share basis, so changes and growth rates across a split are not shown. Splits are read from the filings' own restatements, so a share conversion in a merger or reorganization shows up the same way.

Period endedTTM to
2026-06-30
2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
Revenue$344.32M$342.28M$353.79M$345.93M$335.85M$329.36M$381.61M$374.91M$362.41M$311.17M$302.57M
Gross Profitn/a$123.38M$132.34M$128.13M$122.40M$123.54M$138.06M$140.73M$141.41M$124.90M$130.49M
Operating Income$10.99M$3.30M-$123.54M-$4.74M-$31.54M-$37.44M-$19.87M-$31.79M-$3.18M-$12.22M-$3.31M
Depreciation & Amortization$71.56M$78.26M$84.07M$82.87M$82.06M$79.93M$81.05M$81.03M$83.21M$77.64M$98.89M
EBITDA$82.55M$81.56M-$39.47M$78.14M$50.52M$42.49M$61.18M$49.24M$80.04M$65.42M$95.58M
Net Income-$45.00M-$57.69M-$190.26M-$72.38M-$79.62M-$85.44M-$75.51M-$88.31M-$52.98M-$42.71M-$20.97M
EPS (Diluted)n/a-$2.51-$7.19-$3.04-$3.30-$0.82-$0.74-$0.88n/an/an/a
Total Assets$1.98B$1.71B$1.95B$2.15B$2.18B$2.21B$2.29B$2.33B$2.38B$2.37B$2.19B
Total Liabilities$919.05M$1.11B$1.26B$1.24B$1.18B$1.17B$1.33B$1.22B$1.14B$1.02B$689.38M
Shareholders' Equity$1.05B$600.06M$684.56M$894.15M$992.64M$1.03B$956.99M$1.10B$1.23B$1.35B$1.50B
Cash & Equivalents$245.69M$57.62M$21.65M$46.41M$53.65M$59.74M$72.36M$95.69M$77.26M$94.18M$29.23M
Operating Cash Flow$50.75M$6.95M-$79.85M$21.62M$28.30M$38.88M$41.81M$47.40M$54.15M$63.97M$78.72M
Capital Expendituresn/an/an/an/an/an/an/a$16.72M$12.91M$8.28M$7.48M
Free Cash Flown/an/an/an/an/an/an/a$30.68M$41.24M$55.69M$71.25M
Share Repurchasesn/an/an/an/a$0$0$10.54M$21.11M$14.20M$33.60M$12.18M
Dividends Paidn/an/an/an/a$0$0$31.35M$51.43M$55.33M$76.72M$75.43M
Shares Outstandingn/a28.43M28.30M27.89M26.27M99.28M93.78M92.36M91.96M91.00M89.37M
Dividends Per Sharen/an/a$0.85$0.85$0.85n/a$0.42$0.83$0.92$1.51$1.70
Weighted Average Diluted Sharesn/a28.30M28.29M28.28M28.26M112.97M106.12M100.09Mn/an/an/a
EPS (Basic)n/a-$2.51-$7.19-$3.04-$3.30-$0.82-$0.74-$0.88n/an/an/a

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView